ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,255.20
      1.29%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.785
      0.33%
      Bitcoin
      67,614.37
      0.01%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AN2 Therapeutics Inc (ANTX)

      7. AN2 Therapeutics Inc (ANTX) Financials

      AN2 Therapeutics Inc

      AN2 Therapeutics Inc (ANTX)

      NASDAQ
      2.91
      0.12
      (4.30%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      2.86
      0.00
      (0.00%)
      After Hours: 6:00PM
      Delayed by 15 minutes

      AN2 Therapeutics Inc Financial Summary

      The current ANTX market cap is 86.8M. The company's latest EPS is USD -2.1701 and P/E is -1.32.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -16.04M-16.6M-18.18M-18.82M-18.3M
      Net Income -15.32M-15.8M-16.71M-16.9M-16.62M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -21.61M-42.26M-69.64M
      Net Income -28.06M-42.78M-64.73M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Total Assets 91.08M98.93M153.81M138.74M121.26M
      Total Liabilities 8.57M11.16M14.84M14.04M10.66M
      Total Equity 82.52M87.76M138.97M124.7M110.6M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 65.32M102.56M138.74M
      Total Liabilities 3.41M7.19M14.04M
      Total Equity -47.41M95.37M124.7M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Operating -11.6M-24.42M-36.22M-53.29M-17.59M
      Investing 10.89M18.76M-43.7M-43.28M26.29M
      Financing 199k19.25M85.32M84.99M349k
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -20.48M-33.46M-53.29M
      Investing -50.02M-21.77M-43.28M
      Financing 78.54M70.36M84.99M

      Stats and Ratios

      Market Cap 86.8M
      Price to Earnings Ratio -1.32
      Price to Sales Ratio 0
      Price to Cash Ratio 5.45
      Price to Book Ratio 0.68
      Dividend Yield -

      Share Statistics

      Shares Outstanding 29.83M
      Average Volume (1 week) 129.19k
      Average Volume (1 Month) 164.44k
      52 Week Change -62.88%
      52 Week High 22.22
      52 Week Low 1.91
      Spread (Intraday) 0.31 (10.65%)

      Company Info

      Company Name AN2 Therapeutics Inc
      Address 850 new burton road
      dover, delaware 19904
      Website https://www.an2therapeutics.com
      Industry pharmaceutical preparations (2834)